Virios Therapeutics soars 17% on promising IMC-1 data in Phase 2a fibromyalgia trial
June 09 2021 - 7:34AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Virios Therapeutics (NASDAQ:VIRI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Virios Therapeutics (NASDAQ:VIRI)
Historical Stock Chart
From Apr 2023 to Apr 2024